Man Group
CGEM icon

Man Group’s Cullinan Oncology CGEM Stock Holding History

Man Group’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,341
Closed -$168K – 2242
2025
Q2 		$168K Buy
+22,341
New +$180K ﹤0.01% 2094

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Man Group's CGEM Position: Q3 2025 in Review

Man Group sold out of Cullinan Oncology (CGEM) in Q3 2025, closing a stake of 22,341 shares — an estimated $168K sold.

Man Group first reported a position in CGEM in Q2 2025 and held it in 1 quarter. The position peaked at $168K in Q2 2025. 145 funds tracked by Wall St. Rank hold CGEM as of Q3 2025.

  • Man Group reported no remaining Cullinan Oncology position as of Q3 2025 after selling out during the quarter.
  • Man Group sold 22,341 Cullinan Oncology shares in Q3 2025, an estimated $168K.
  • Man Group first reported a position in Cullinan Oncology in Q2 2025 and held it in 1 quarter.
  • Man Group's Cullinan Oncology position peaked at $168K in Q2 2025.
  • 145 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2025.

Based on Man Group's 13F filing for Q3 2025, filed 14 Nov 2025.